FDAnews
www.fdanews.com/articles/206196-united-ppe-americas-crispr-sars-cov-2-test-kit-gets-ce-mark

United PPE America’s CRISPR SARS-CoV-2 Test Kit Gets CE Mark

January 18, 2022

United PPE America has received a CE mark certification for its CRISPR SARS-CoV-2 test kit which uses genetic engineering technology licensed from Cambridge, Mass.-based Sherlock Biosciences.

The test has specificity and sensitivity on par with conventional polymerase chain reaction (PCR) testing methods and a turnaround time from sample to read-out of less than one hour, according to United PPE.

Sherlock Biosciences CEO, Bryan Dechairo, said the company’s CRISPR diagnostic technology can enable increased access to diagnostics globally.

View today's stories